This review discusses the use of the 23-valent pneumococcal polysaccharide vaccine PNEUMOVAX® 23 (PPV-23), which protects against 23 different types of pneumococcal bacteria responsible for an estimated 90% of cases of life-threatening invasive pneumococcal disease (IPD).
Download PDF